Cancer
In this noteworthy interview, CTSNet Editor-in-Chief Joel Dunning speaks with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San Francisco, California, USA, and a thoracic...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Timur Kyashif, a cardiac resident at Jena University Hospital in Jena, Germany, about the German Society for Thoracic, Cardiac,...
In this noteworthy interview, CTSNet Editor-in-Chief Joel Dunning speaks with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San Francisco,...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San...
This Society of Thoracic Surgeons Expert Consensus Documents provides updated, multidisciplinary guidance on the multimodal management of pleural mesothelioma (PM). The expert panel emphasizes that surgical resection should only be...
The authors present a robotic-assisted right bilobectomy performed for coexisting right upper lobe bronchiectasis and synchronous middle lobe adenocarcinoma, highlighting the management of dual pathology in the setting of dense...
Anatomic segmentectomy has emerged as an effective option for the management of early-stage lung cancer; however, the division of intersegmental parenchyma remains technically challenging. The authors describe and illustrate the...
At the Society for Cardiothoracic Surgery in Great Britain and Ireland Annual Meeting, leading surgeons presented on challenges in the management of locally advanced non-small cell lung cancer (NSCLC). Dr....
This article presents a large, population-based study using UK primary care data to identify comorbid conditions associated with lung cancer in never-smokers (LCINS). Across two independent data sets (CPRD-GOLD and...
This article reviews recent efforts to evaluate the use of osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in the neoadjuvant setting for patients with resectable EGFR-mutant non-small cell lung...
This retrospective analysis compared three-port and four-port robotic-assisted thoracoscopic surgery (RATS) lobectomy for non-small cell lung cancer (NSCLC)(n=121, 2020–2021). Demographics, tumor characteristics, complications, and lymph node yields were similar between...
This article presents a comprehensive epidemiological analysis of lung cancer, focusing on subtype-specific patterns worldwide. Using data from GLOBOCAN 2022 and other international cancer registries, the study estimated more than...
Lung cancer remains the leading cause of cancer-related deaths, and low-dose computed tomography screening can reduce mortality for high-risk individuals. In 2021, the US Preventive Services Task Force (USPSTF) expanded...



